Inventor · disambiguated record
Frederic Leroy
Also filed as: LEROY FREDERIC
7 granted patents·4 pending applications·125 citations·filing 2004–2014
87Inventor score
Files withIDENIX PHARMACEUTICALS INC4CENTRE NAT RECH SCIENT1DOUSSON CYRIL1GOSSELIN GILLES1INDENIX PHARMACEUTICALS INC1
Top patents by PatentIndex Score
11 records- 0195US8742101B2Purine nucleoside analogues for treating flaviviridae including hepatitis CSTORER RICHARD·Filed 2008·Granted Jun 3, 2014·40 cites·38 claims
- 0290US8193372B2Phosphothiophene and phosphothiazole HCV polymerase inhibitorsDOUSSON CYRIL·Filed 2010·Granted Jun 5, 2012·37 cites·29 claims
- 0387US9186369B2Purine nucleoside analogues for treating flaviviridae including hepatitis CIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Nov 17, 2015·8 cites·28 claims
- 0487US8377962B2Macrocyclic serine protease inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2010·Granted Feb 19, 2013·14 cites·93 claims
- 0584US8993595B2Macrocyclic serine protease inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Mar 31, 2015·8 cites·96 claims
- 0682US9284307B2Macrocyclic serine protease inhibitorsPARSY CHRISTOPHE CLAUDE·Filed 2010·Granted Mar 15, 2016·8 cites·18 claims
- 0782US8003659B2Macrocyclic serine protease inhibitorsINDENIX PHARMACEUTICALS INC·Filed 2009·Granted Aug 23, 2011·10 cites·189 claims
- 0856US2005075309A1Purine nucleoside analogues for treating Flaviviridae including hepatitis CFiled 2004·Application pending·0 cites
- 0952US2009047244A1Macrocyclic serine protease inhibitors iIDENIX PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1045US2007185063A1Seven-membered ring nucleosidesCENTRE NAT RECH SCIENT·Filed 2006·Application pending·0 cites
- 1141US2006040944A15-Aza-7-deazapurine derivatives for treating FlaviviridaeGOSSELIN GILLES·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frederic Leroy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →